Edition:
United States

Piramal Enterprises Ltd (PIRA.NS)

PIRA.NS on National Stock Exchange of India

2,496.35INR
28 Apr 2017
Change (% chg)

Rs20.85 (+0.84%)
Prev Close
Rs2,475.50
Open
Rs2,471.90
Day's High
Rs2,512.00
Day's Low
Rs2,455.95
Volume
174,421
Avg. Vol
127,423
52-wk High
Rs2,534.00
52-wk Low
Rs1,101.00

PIRA.NS

Chart for PIRA.NS

About

Piramal Enterprises Limited (PEL) is engaged in the business of pharmaceuticals, including research and development, financial services and information management through its subsidiaries. The Company's pharmaceutical business consists of manufacturing and sale of own and traded bulk drugs and formulations. It operates through... (more)

Overall

Beta: 0.54
Market Cap(Mil.): Rs430,777.91
Shares Outstanding(Mil.): 172.56
Dividend: 17.50
Yield (%): 0.70

Financials

  PIRA.NS Industry Sector
P/E (TTM): 38.41 29.08 30.08
EPS (TTM): 65.00 -- --
ROI: -- 13.73 13.25
ROE: -- 14.68 14.41

BRIEF-Piramal Enterprises completes drug portfolio acquisition from Mallinckrodt LLC

* Piramal Enterprises completes acquisition of a portfolio of drugs for spasticity and pain management from Mallinckrodt LLC Source text: (http://bit.ly/2n55MD8) Further company coverage:

Mar 19 2017

BRIEF-Piramal enterprises and Ivanhoé Cambridge to invest in residential development

* Says Piramal Enterprises and Ivanhoé Cambridge announce partnership to invest in residential development in India

Feb 23 2017

BRIEF-Piramal Enterprises Dec qtr consol profit up about 32 pct

* Dec quarter consol total income from operations 23.42 billion rupees

Feb 13 2017

BRIEF-Piramal Enterprises unit buys portfolio of drugs from Mallinckrodt LLC

* Says Piramal Enterprises announces acquisition of a portfolio of drugs for spasticity and pain management from Mallinckrodt Llc

Jan 30 2017

More From Around the Web

Earnings vs. Estimates